We’re excited to announce that uMethod is one of eight portfolio companies to receive a follow-on investment from the Triangle Tweener Fund in their Q3 2024 round! This continued support highlights the growing confidence in our AI-driven healthcare solutions as we work toward improving patient outcomes. Read more about the fund and our journey here: www.tweenerfund.com. Thank you to the Triangle Tweener Fund for believing in our vision! Together, we’re…READ MORE

PHILADELPHIA, July 30, 2024 /PRNewswire/ -- uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer's and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning. With the increasing prevalence of cognitive impairment, including…READ MORE

Raleigh, NC – July 8, 2024 – uMethod Health, a trailblazer in precision medicine and personalized health solutions, proudly announces the appointment of Dr. Ida Crocker-Sabbagh as its Chief Medical Officer (CMO). Dr. Crocker-Sabbagh's extensive clinical expertise and groundbreaking work in Alzheimer's disease prevention elevate uMethod Health's commitment to transforming patient care through innovative technology and personalized care plans. With a distinguished career spanning over three decades, Dr. Crocker-Sabbagh specializes…READ MORE

Michael K. Racke, MD, medical director of neurology at Quest Diagnostics, delved into some commonly-believed myths about Alzheimer disease and provided his insight on the scientific explanations for these assumptions. Common myths:#1: Only older patients need to worry about AD. #2: AD is primarily an inherited genetic disease. #3: Most patients don’t want to know if they are at risk of developing AD. #4: Only high-powered imaging tests can help evaluate for AD. #5: Only…READ MORE

As a part of its efforts during Alzheimer's Awareness Month, uMETHOD is educating the public on the risk factors associated with Alzheimer's and the importance of early intervention. Alzheimer's disease is a progressive brain disorder that affects 5.7 million U.S. adults, with many more in preceding stages of decline. The impacts of the disease are devastating and extend beyond memory loss. Alzheimer's and dementia can bring pain, stress, financial ruin,…READ MORE

OKLAHOMA CITY, Oct. 17, 2023 -- Tribal Diagnostics, a high-complexity diagnostics laboratory, has announced availability of the RestoreU™ Dementia Panel throughout Texas and Oklahoma. RestoreU is a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. RestoreU's Assistive AI improves care for individuals suffering from chronic diseases like Alzheimer's with multiple underlying medical causes. It creates…READ MORE

…READ MORE

Alzheimer’s is a disease of data. The disease doesn’t have what we typically react to quickly: There is no pain, no blood, no pus, no rash, no dry mouth, nothing is visibly out of kilter.  Yet, Alzheimer’s disease generally starts its destruction 20 years before symptoms (most notably memory loss) are acknowledged. There can be more than 50 treatable causes to be dealt with simultaneously. More than half of the…READ MORE

Raleigh-based uMethod was founded in 2013 to help doctors treat patients suffering from cognitive problems like dementia and Alzheimer’s. The SaaS platform provides a service to doctors, who order blood tests for a patient suffering from cognitive decline in order to create a personalized AI-generated care plan.  AI collects data on patients from blood tests ordered by their doctor and devises a treatment plan by analyzing treatable causes such as infection, inflammation,…READ MORE

RESEARCH TRIANGLE PARK – Triangle Tweener Fund continues to provide fuel for the region’s startup ecosystem, cranking out 18 investments and adding 14 additional companies to its portfolio in the last three months. “This is up 20% year over year deal wise and 30% investment wise,” says Tweener fund founder and serial entrepreneur Scot Wingo. The fund was established last year and targets startups headquartered in the Research Triangle Park. So far…READ MORE